Elevance Health Inc.
ELVLast close · Oct 16, 2026428.26−0.17 (−0.04%)
Market cap$92.9B
Key indicators
Revenue201.1B+6.3% on a year earlier
92.1B
104.2B
121.9B
138.6B
156.6B
171.3B
177.0B
199.1B
201.1B
197.1B
201.4B
211.9B
Fiscal year
FY201818
FY201919
FY202020
FY202121
FY202222
FY202323
FY202424
FY202525
TTMTTM
FY2026E26E
FY2027E27E
FY2028E28E
| Fiscal year | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM | FY2026E | FY2027E | FY2028E |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Growth | ||||||||||||
| 92.1B | 104.2B+13.1% | 121.9B+16.9% | 138.6B+13.8% | 156.6B+13.0% | 171.3B+9.4% | 177.0B+3.3% | 199.1B+12.5% | 201.1B+6.3% | 197.1B | 201.4B | 211.9B | |
| — | 13.1% | 16.9% | 13.8% | 13.0% | 9.4% | 3.3% | 12.5% | 6.3% | -1.0% | 2.2% | 5.2% | |
| $14.19 | $18.47+30.2% | $17.98−2.7% | $24.73+37.5% | $24.81+0.3% | $25.22+1.7% | $25.68+1.8% | $25.21−1.8% | $22.59−3.9% | $27.24 | $29.63 | $33.99 | |
| Profitability | ||||||||||||
| 5.9% | 5.8%−0.1 pt | 5.2%−0.5 pt | 5.4%+0.2 pt | 5.4%−0.0 pt | 5.0%−0.4 pt | 4.4%−0.5 pt | 3.6%−0.8 pt | 2.7%−1.3 pt | · | · | · | |
| 4.1% | 4.6%+0.5 pt | 3.8%−0.9 pt | 4.4%+0.7 pt | 3.8%−0.6 pt | 3.5%−0.4 pt | 3.4%−0.1 pt | 2.8%−0.5 pt | 2.5%−0.4 pt | · | · | · | |
| 13.1% | 15.2%+2.0 pt | 13.8%−1.4 pt | 16.9%+3.2 pt | 16.6%−0.3 pt | 15.2%−1.4 pt | 14.5%−0.8 pt | 12.9%−1.6 pt | — | · | · | · | |
| Cash | ||||||||||||
| 2.6B | 5.0B+90.3% | 9.7B+94.0% | 7.3B−24.7% | 7.2B−0.4% | 6.8B−6.7% | 4.6B−32.7% | 3.2B−30.3% | 6.3B+17.8% | · | · | · | |
| 2.8% | 4.8%+1.9 pt | 7.9%+3.1 pt | 5.2%−2.7 pt | 4.6%−0.6 pt | 3.9%−0.7 pt | 2.6%−1.4 pt | 1.6%−1.0 pt | 3.1%+0.3 pt | · | · | · | |
| 776.0M | 818.0M+5.4% | 954.0M+16.6% | 1.1B+15.7% | 1.2B+11.3% | 1.4B+13.5% | 1.5B+8.1% | 1.5B+1.4% | — | · | · | · | |
| Balance sheet | ||||||||||||
| 0.67x | 0.63x−0.04x | 0.60x−0.03x | 0.64x+0.04x | 0.66x+0.03x | 0.64x−0.03x | 0.76x+0.12x | 0.73x−0.03x | 0.69x+0.00x | · | · | · | |
| 264.20M | 260.30M−1.5% | 254.30M−2.3% | 246.80M−2.9% | 242.80M−1.6% | 237.40M−2.2% | 232.90M−1.9% | 224.60M−3.6% | 217.90M−3.5% | · | · | · | |
E = analyst consensus (revenue and EPS only). TTM = the twelve months to Jun 30, 2026: the last fiscal year, plus the quarters since, less the same quarters a year earlier. From the 10-K and the 10-Qs since, as accepted by the SEC; the shaded column is the latest period.